Slide background
Slide background
Slide background

Our Expertise

ian-boultonBefore founding TropMed Pharma Consulting, Ian Boulton spent his entire professional career working in the pharmaceutical industry. In over 30 years working with Glaxo, SmithKline & French, SmithKline Beecham, and GlaxoSmithKline (GSK), he has held roles in a wide variety of functions – R&D, Sales, Marketing, Business Development, Strategic Planning, & General Management.

    • Bill & Melinda Gates Foundation
    • Bundesministerium für Bildung und Forschung (Germany)
    • Department of Foreign Affairs & Trade (Australia)
    • Department for International Development (UK)
    • FIND
    • GBCHealth
    • Global Fund to fight AIDS, TB & Malaria
    • Innovative Vector Control Consortium
    • Liverpool School of Tropical Medicine
    • London School of Hygiene & Tropical Medicine
    • Malaria No More UK
    • Medicines for Malaria Venture
    • Roll Back Malaria Partnership
    • TB Alliance
    • UNITAID
    • University of York CNAP Programme
    • Private companies working on drugs, vector control, and other commodities.
  • Ian spent 20 years based in the Asia-Pacific Region – principally in Japan, Thailand, & a regional role based in Singapore.

    After the GlaxoSmithKline merger in 2001 until his retirement in 2008, Ian was Director, Global Commercial Strategy – Diseases of the Developing World (DDW) within the R&D organisation of GSK. He led the team that developed and owned GSK’s strategy for the discovery, development, and deployment of drugs to treat the major diseases that disproportionately affect the poorest countries.

    His role also involved developing and maintaining target profiles for GSK’s DDW portfolio and then ensuring that projects remained focused right up till registration and launch on delivering products that met the specific needs of patients in the developing world. He was also responsible for developing the launch strategies for these products, which were mostly to be marketed only in developing countries (with their unique challenges). Most of these projects were carried out as product development partnerships (PDPs). He has extensive experience of working in collaborative PDPs with academic institutions (e.g. Liverpool School of Tropical Medicine, London School of Hygiene & Tropical Medicine), Government organisations (e.g. Walter Reed Army Institute of Research, National Institutes of Health), funding organisations (e.g. Medicines for Malaria Venture, the Global Alliance for TB Drug Development, Bill & Melinda Gates Foundation, Wellcome Trust), and intergovernmental organisations (e.g. World Health Organisation).
  • Ian is recognised as a leading figure in the global effort to control, eliminate, and ultimately eradicate malaria. Between 2004 and 2008 he was a Board Member of the Roll Back Malaria Partnership (RBM) – the global collaboration between governments, NGOs, civil society, and the private sector to tackle malaria worldwide. He was a member of the Partnership’s Executive Committee, the Performance & Evaluation Sub-committee, & an advisor to the Partnership’s Task Force on the Affordable Medicines Facility – malaria (AMFm). In 2009-10, he was the Consultant to the Board's Performance and Accountability Task Force. In 2012-13 he was the consultant supporting the Chair of the RBM AMFm Task Force, as well as a member of the Task Force in his own right. He has also been a member of the Partnership's Transition Support Team, which implemented the changes to the Partnership agreed by its Board in December 2015.

    Between 2009 and 2011 Ian represented the Private Sector on the Global Fund to fight AIDS, TB, & Malaria's ad hoc Market Dynamics and Commodities Committee. He has also acted as an advisor to the Fund on product QA policy and on AMFm. Between 2012 and 2014 he was a member of the Fund's Market Dynamics Advisory Group (MDAG) and the MDAG Working Group on AMFm.

    Ian was also a member of the Board of Trustees of the Malaria Consortium between 2009 and 2015. The Consortium is one of the world’s leading not-for-profit organisation dedicated to the control of malaria. He served on the Board's Governance and Compensation Committees. He is currently a non-Trustee member of the Finance, Audit, & Risk Committee.
  • Ian’s expertise is often called upon to participate in panels and to give presentations on his areas of expertise. Events and organizations he has spoken at include:-
    • Academy of Medical Sciences
    • All Party Parliamentary Group on Malaria & Neglected Tropical Diseases
    • International Society for Neglected Tropical Diseases 2015
    • UNITAID Malaria Market Forum 2012
    • Friends of ALMA Manufacturers' Forum 2011
    • Pan-African National Malaria Control Programs Meeting 2012
    • WHO-MMV Artemisinin Forums 2008 and 2009
    • Asia-Pacific Technology Network
    • Cambridge Science Week 2008
    • Artemisinin Enterprise Conference 2008
    • Euro-Africa Health Investment Conference 2012
    • “Connecting the Chain” Stakeholder Forum 2006 (organised by the Netherlands Foreign Ministry).

Find out more about Ian's experience

Click here to view Ian’s Curriculum Vitae